Ultra-high Radiofrequency Hyperthermia is the fastest growing segment fueling the growth of Hyperthermia Cancer Treatment Market

 

Hyperthermia Cancer treatment Market

The global Hyperthermia Cancer Treatment Market is estimated to be valued at US$ 187.05 Bn or billion in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

The hyperthermia cancer treatment market involves the usage of heat therapy to destroy or reduce the size of tumors. Heat therapy achieves this by damaging and killing cancer cells or making them more sensitive to the effects of radiation and certain anti-cancer drugs. This market utilizes heat treatments like radiofrequency hyperthermia and microwave hyperthermia for tumor ablation.

 

Market key trends:

One of the key trends in the hyperthermia cancer treatment market is the growing adoption of ultra-high radiofrequency hyperthermia. Ultra-high frequencies ranging from 13.56 MHz to 100 MHz are being utilized to treat cancerous tumors localized in the body. The higher frequencies allow for better penetration depth within tissues to destroy tumors effectively. Research and development is ongoing to enhance the utilization of ultra-high frequencies to treat cancers that were previously difficult to treat with hyperthermia. Ongoing clinical research studies are evaluating the safety and efficacy of ultra-high RF hyperthermia to tackle cancers like those in the pancreas and lung. Along with localized therapy, efforts are also examining its role in improving the efficacy of chemotherapy and radiotherapy.

Segment Analysis

The global hyperthermia cancer treatment market is segmented into two categories based on technology: hyperthermia devices and hyperthermia disposables. The hyperthermia devices segment dominates the market and is expected to continue its dominance over the forecast period. This is because hyperthermia devices such as microwave hyperthermia devices are used repeatedly to treat cancer, making them a worthwhile long-term investment for hospitals and cancer treatment centers.

 

Key Takeaways

The Global Hyperthermia Cancer Treatment Market Size is expected to witness high growth, exhibiting a CAGR of 6.1% over the forecast period, due to increasing cases of cancer worldwide.

 

North America dominates the global hyperthermia cancer treatment market currently due to high awareness regarding cancer treatment options and availability of advanced healthcare facilities in the region. Europe holds the second largest share in the market owing to rising healthcare expenditure and government support for cancer treatment.

 

Key players operating in the hyperthermia cancer treatment market are MagForce AG, Andromedic, Xianke Medical Equipment, OncoTherm, Celsius42+, Oncotherm, Pyrexar Medical, Yamamoto Vinita, Nanoprobes, Alba Hyperthermia System, Nova Company, Perseon, Omron, Sunny Medical Equipment, OrienTech, BSD Medical, Sensius, Celsius42, Nanjing Greathope, Shanghai Huayuan. The global hyperthermia cancer treatment market is growing owing to increasing adoption of hyperthermia as an effective treatment for cancer worldwide.

Read more

https://www.dailyprbulletin.com/hyperthermia-cancer-treatment-market-size-share-growth-outlook-2023/

Comments

Popular posts from this blog

Clamshell Packaging Market to Grow at High Rate Owing to Rising Demand for Sustainable Packaging Options

Global Veterinary Equipment and Disposables Market: Trends and Outlook

"Advancements in Wilson's Disease Treatment: A Market Analysis"